Did fenofibrate – a common cholesterol drug – reverse one 19-year old woman’s newly diagnosed Type 1 diabetes?
This is the question at the heart…
Category: Science
We all know that in Type 1 diabetes, the pancreas’ beta cells cease to function. But are they eliminated? Do they die? Or are they merely “stunned?”…
Aaron J. Kowalski, Ph.D., President and CEO of JDRF has issued a statement based on two new reports issued by the Centers for Disease Control and…
Is Type 1 diabetes dramatically more common than is widely understood? That’s the contention of Dr. David Leslie, Professor of Diabetes and Immunology…
Researchers Raise Doubt Over Major Diabetes Drug Trials
The FDA requires pharmaceutical companies developing diabetes drugs to run trials to…
JDRF is calling 2019, “a banner year for Type 1 diabetes breakthroughs.” Check out their list below to find out their top ten diabetes…
The U.S. FDA has authorized marketing of the Tandem Diabetes Care Control-IQ Technology, an interoperable automated glycemic controller device…
JDRF has announced the launch of the JDRF Northern California Center of Excellence, to accelerate high-impact research at Stanford University…
The 2019 recipient of the American Diabetes Association Kelly West Award for Outstanding Achievement in Epidemiology talks about the most pressing…
The results of a promising clinical trial were released earlier this month during the American Diabetes Association’s annual “Scientific Sessions”…